Skin Sparing Mastectomy and Immediate Breast Reconstruction With Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy (M-RIC)
- Conditions
- Breast Carcinoma
- Registration Number
- NCT01199354
- Lead Sponsor
- Clinique Clementville
- Brief Summary
The aim of the study is to evaluate the feasibility and morbidity of skin sparing mastectomy and immediate breast reconstruction with latissimus dorsi flap after neoadjuvant chemotherapy and radiotherapy in invasive breast carcinoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 80
- Women < 75 year old
- Invasive breast carcinoma, indication for mastectomy
- Women Health Organization (WHO) score of 0 and 1, primary chemotherapy, external radiotherapy performed less than 8 week earlier...
- Women older than 75
- Metastatic breast carcinoma
- Antecedents of previously treated homolateral breast carcinoma
- Documented cancer progression
- Smoker at the moment of the indication surgery
- Known diabetes, neoadjuvant hormonal treatment...
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Incidence of skin necrosis To evaluate the incidence of skin necrosis in case of treatment with skin sparing mastectomy and immediate breas reconstruction with latissimus dorsi myocutaneous flap after neoadjuvant chemotherapy and radiotherapy.
- Secondary Outcome Measures
Name Time Method Rate of histological remission of the surgical specimen based on the anatomopathological examination
Trial Locations
- Locations (9)
Polyclinique Urbain V
🇫🇷Avignon, France
Centre Léon Bérard
🇫🇷Lyon, France
Centre Jean Perrin
🇫🇷Clermont-Ferrand, France
Clinique Belledonne
🇫🇷Saint Martin d'Hères, France
Groupe Hospitalier Mutualiste Clinique les Eaux Claires
🇫🇷Grenoble, France
Clinique Clementville
🇫🇷Montpellier, France
Institut Paoli Calmettes
🇫🇷Marseille, France
Institut Claudius Regaud
🇫🇷Toulouse, France
CRLCC Val d'Aurelle
🇫🇷Montpellier, France